Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular AMD: End of Study Results

Franco Recchia; Steven Blotner; Natasha Singh; Giulio Barteselli; Shamika Gune

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1155. doi:

ARVO Annual Meeting Abstract June 2013

One-year results of the Prospective Retinal and Optic nerve Vitrectomy Evaluation (PROVE) Study: A controlled clinical trial

Rohan Shah; Maziar Lalezary; Stephen Kim; Rahul Reddy; Jeffrey Kammer; Rachel Kuchtey; Karen Joos; Franco Recchia; Edward Cherney; Janice Law

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5779. doi:

ARVO Annual Meeting Abstract March 2012

Three month results of the Prospective Retinal and Optic nerve Vitrectomy Evaluation (PROVE) study: a controlled clinical trial

Scott D. Schoenberger; Maziar Lalezary; Stephen J. Kim; Jeffrey A. Kammer; Rachel W. Kuchtey; Karen Joos; Franco M. Recchia; Edward F. Cherney

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3788. doi:

ARVO Annual Meeting Abstract April 2011

Elevation of Vitreous Endocan Levels in Proliferative Diabetic Retinopathy

Ajay Shalwala; Philippe Lassalle; Nathalie De Freitas Caires; Maryse Delehedde; Kevin Wise; Hassanain Toma; Erin Fulchiero; Franco Recchia

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1295. doi:

ARVO Annual Meeting Abstract April 2011

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study: 3-Month Results

Maziar Lalezary; Rahul K. Reddy; Edward F. Cherney; Franco M. Recchia; Karen M. Joos; Jeffrey A. Kammer; Rachel W. Kuchtey; Stephen J. Kim

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6131. doi:

ARVO Annual Meeting Abstract April 2010

Systemic Adverse Events Among Infants With Retinopathy of Prematurity (rop) Treated With Intravitreal Bevacizumab: Determination of a Statistically Valid Cohort

R. Reddy; F. Recchia; S. Steele; P. Lu

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5228. doi:

ARVO Annual Meeting Abstract April 2010

Long-Term Potency, Sterility, and Stability of Vancomycin, Ceftazidime, and Moxifloxacin for Intravitreal Use in the Treatment of Endophthalmitis

B. K. Armstrong; S. Mehta; S. J. Kim; F. Recchia; L. L. Wayman; H. Toma; H. Yin; P. Sternberg

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6043. doi:

ARVO Annual Meeting Abstract April 2010

Long-Term Trends in Intraocular Pressure After Pars Plana Vitrectomy

M. Lalezary; S. J. Kim; K. Jiramongkolchai; F. M. Recchia; A. Agarwal; P. Sternberg

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2562. doi:

ARVO Annual Meeting Abstract April 2010

The Apelin/APJ Pathway in Retinal Angiogenesis

F. M. Recchia; L. Xu; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):28. doi:

ARVO Annual Meeting Abstract April 2010

Spectral-Domain OCT Findings in Children With a History of Prematurity: A Prospective, Controlled Study

L. F. Kehler; F. M. Recchia; P. Itharat; J. Sonsino; C. C. Recchia; J. A. Kammer

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5296. doi:

ARVO Annual Meeting Abstract April 2010

Ocular Consequences of Bottle Rocket Injuries in Children

M. Khan; D. A. Reichstein; F. M. Recchia

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5379. doi:

ARVO Annual Meeting Abstract April 2010

Vitreous Levels of Apelin, a Novel Angiogenic Cytokine, Are Increased in Proliferative Diabetic Retinopathy

K. B. Wise; H. Toma; L. Xu; F. M. Recchia

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5634. doi:

Retina February 2010

Identification of Genes and Pathways Involved in Retinal Neovascularization by Microarray Analysis of Two Animal Models of Retinal Angiogenesis

PDF

Franco M. Recchia; Lili Xu; John S. Penn; Braden Boone; Phillip J. Dexheimer
TAGS: angiogenesis, animal model, gene expression, genes, retinal neovascularization, mice, reverse transcriptase polymerase chain reaction
Invest. Ophthalmol. Vis. Sci.. 2010; 51(2):1098-1105. doi: https://doi.org/10.1167/iovs.09-4006

ARVO Annual Meeting Abstract April 2009

Ascorbate Decreases Vascular Endothelial Growth Factor Production in Rat Retina

W. Wu; L. Xu; J. Penn; F. Recchia

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):53. doi:

ARVO Annual Meeting Abstract April 2009

Combined 25-gauge Pars Plana Vitrectomy and Posterior Tube Shunt for Refractory Glaucoma

D. A. Reichstein; J. Kammer; F. M. Recchia

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2067. doi:

ARVO Annual Meeting Abstract April 2009

Microarray Analysis of Experimental Retinal Neovascularization Identifies New Targets and Pathways

F. M. Recchia; L. Xu; B. Boone; P. Dexheimer

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2944. doi:

ARVO Annual Meeting Abstract April 2009

Ascorbate and Health Maintenance in Cultured Rat Retinal Endothelial Cells

L. Xu; W. Wu; J. S. Penn; F. M. Recchia

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2959. doi:

ARVO Annual Meeting Abstract April 2009

Does Antifungal Prophylaxis Affect the Incidence and Severity of Retinopathy of Prematurity in Extremely Low Birth Weight Infants?

K. B. Wise; J.-H. Weitkamp; F. M. Recchia

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3153. doi:

ARVO Annual Meeting Abstract May 2008

A Comparison Between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients With Clinically Significant Macular Edema

R. Shah; K. Galler; F. Recchia

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4245. doi:

ARVO Annual Meeting Abstract May 2007

Visual Acuity as a Component of a Digital Diabetic Eye Screening Protocol

L. F. Kehler; B. Barahimi; U. S. Rao; L. M. Merin; C. C. Recchia; A. S. Chomsky; F. M. Recchia

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):328. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular AMD: End of Study Results

One-year results of the Prospective Retinal and Optic nerve Vitrectomy Evaluation (PROVE) Study: A controlled clinical trial

Three month results of the Prospective Retinal and Optic nerve Vitrectomy Evaluation (PROVE) study: a controlled clinical trial

Elevation of Vitreous Endocan Levels in Proliferative Diabetic Retinopathy

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study: 3-Month Results

Systemic Adverse Events Among Infants With Retinopathy of Prematurity (rop) Treated With Intravitreal Bevacizumab: Determination of a Statistically Valid Cohort

Long-Term Potency, Sterility, and Stability of Vancomycin, Ceftazidime, and Moxifloxacin for Intravitreal Use in the Treatment of Endophthalmitis

Long-Term Trends in Intraocular Pressure After Pars Plana Vitrectomy

The Apelin/APJ Pathway in Retinal Angiogenesis

Spectral-Domain OCT Findings in Children With a History of Prematurity: A Prospective, Controlled Study

Ocular Consequences of Bottle Rocket Injuries in Children

Vitreous Levels of Apelin, a Novel Angiogenic Cytokine, Are Increased in Proliferative Diabetic Retinopathy

Identification of Genes and Pathways Involved in Retinal Neovascularization by Microarray Analysis of Two Animal Models of Retinal Angiogenesis

Ascorbate Decreases Vascular Endothelial Growth Factor Production in Rat Retina

Combined 25-gauge Pars Plana Vitrectomy and Posterior Tube Shunt for Refractory Glaucoma

Microarray Analysis of Experimental Retinal Neovascularization Identifies New Targets and Pathways

Ascorbate and Health Maintenance in Cultured Rat Retinal Endothelial Cells

Does Antifungal Prophylaxis Affect the Incidence and Severity of Retinopathy of Prematurity in Extremely Low Birth Weight Infants?

A Comparison Between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients With Clinically Significant Macular Edema

Visual Acuity as a Component of a Digital Diabetic Eye Screening Protocol

To View More...

You must be signed into an individual account to use this feature.